▶ 調査レポート

腹部大動脈瘤治療薬の世界市場2020年：メーカー別、地域別、種類・用途別
• 英文タイトル：Global Abdominal Aortic Aneurysm Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。腹部大動脈瘤治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 / Global Abdominal Aortic Aneurysm Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / MRC2012A0006資料のイメージです。• レポートコード：MRC2012A0006
• 出版社/出版日：GlobalInfoResearch / 2020年12月21日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、101ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医薬品、医療
• 販売価格（消費税別）
  Single User￥522,000 (USD3,480)▷ お問い合わせ
  Multi User￥783,000 (USD5,220)▷ お問い合わせ
  Corporate User￥1,044,000 (USD6,960)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
本調査レポートでは、腹部大動脈瘤治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。腹部大動脈瘤治療薬の種類別市場規模（BSN-908、カナキヌマブ、CT-2009、チカグレロル、その他）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：AstraZeneca Plc、Vida Therapeutics Inc.、Carolus Therapeutics, Inc.、Novartis AG、
・地域別グローバル市場分析 2015年-2020年
・腹部大動脈瘤治療薬の北米市場（アメリカ、カナダ、メキシコ）
・腹部大動脈瘤治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア）
・腹部大動脈瘤治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア）
・腹部大動脈瘤治療薬の南米市場（ブラジル、アルゼンチン）
・腹部大動脈瘤治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ）
・種類別分析：BSN-908、カナキヌマブ、CT-2009、チカグレロル、その他
・用途別分析：病院、診療所、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Abdominal Aortic Aneurysm Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Abdominal Aortic Aneurysm Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Abdominal Aortic Aneurysm Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Abdominal Aortic Aneurysm Drug market has been segmented into
BSN-908
Canakinumab
CT-2009
Ticagrelor
Others

By Application, Abdominal Aortic Aneurysm Drug has been segmented into:
Hospital
Clinic
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Abdominal Aortic Aneurysm Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Abdominal Aortic Aneurysm Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Abdominal Aortic Aneurysm Drug market.

The report offers in-depth assessment of the growth and other aspects of the Abdominal Aortic Aneurysm Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Abdominal Aortic Aneurysm Drug Market Share Analysis
Abdominal Aortic Aneurysm Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Abdominal Aortic Aneurysm Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Abdominal Aortic Aneurysm Drug sales, revenue and market share for each player covered in this report.

The major players covered in Abdominal Aortic Aneurysm Drug are:
AstraZeneca Plc
Vida Therapeutics Inc.
Carolus Therapeutics, Inc.
Novartis AG

Among other players domestic and global, Abdominal Aortic Aneurysm Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Abdominal Aortic Aneurysm Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Abdominal Aortic Aneurysm Drug, with price, sales, revenue and global market share of Abdominal Aortic Aneurysm Drug in 2018 and 2019.
Chapter 3, the Abdominal Aortic Aneurysm Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Abdominal Aortic Aneurysm Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Abdominal Aortic Aneurysm Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Abdominal Aortic Aneurysm Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Abdominal Aortic Aneurysm Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Abdominal Aortic Aneurysm Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 BSN-908
1.2.3 Canakinumab
1.2.4 CT-2009
1.2.5 Ticagrelor
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Abdominal Aortic Aneurysm Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Overview of Global Abdominal Aortic Aneurysm Drug Market
1.4.1 Global Abdominal Aortic Aneurysm Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca Plc
2.1.1 AstraZeneca Plc Details
2.1.2 AstraZeneca Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AstraZeneca Plc SWOT Analysis
2.1.4 AstraZeneca Plc Product and Services
2.1.5 AstraZeneca Plc Abdominal Aortic Aneurysm Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Vida Therapeutics Inc.
2.2.1 Vida Therapeutics Inc. Details
2.2.2 Vida Therapeutics Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Vida Therapeutics Inc. SWOT Analysis
2.2.4 Vida Therapeutics Inc. Product and Services
2.2.5 Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Carolus Therapeutics, Inc.
2.3.1 Carolus Therapeutics, Inc. Details
2.3.2 Carolus Therapeutics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Carolus Therapeutics, Inc. SWOT Analysis
2.3.4 Carolus Therapeutics, Inc. Product and Services
2.3.5 Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis AG
2.4.1 Novartis AG Details
2.4.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis AG SWOT Analysis
2.4.4 Novartis AG Product and Services
2.4.5 Novartis AG Abdominal Aortic Aneurysm Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Abdominal Aortic Aneurysm Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Abdominal Aortic Aneurysm Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Abdominal Aortic Aneurysm Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Abdominal Aortic Aneurysm Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Abdominal Aortic Aneurysm Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Abdominal Aortic Aneurysm Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Abdominal Aortic Aneurysm Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020)
4.3 Europe Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020)
4.5 South America Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Abdominal Aortic Aneurysm Drug Sales, Revenue and Market Share by Country
5.1.1 North America Abdominal Aortic Aneurysm Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Abdominal Aortic Aneurysm Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020)
5.3 Canada Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Abdominal Aortic Aneurysm Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Abdominal Aortic Aneurysm Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Abdominal Aortic Aneurysm Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020)
6.3 UK Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020)
6.4 France Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020)
6.5 Russia Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020)
6.6 Italy Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Abdominal Aortic Aneurysm Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Abdominal Aortic Aneurysm Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Abdominal Aortic Aneurysm Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020)
7.3 Japan Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020)
7.4 Korea Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020)
7.5 India Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020)
7.7 Australia Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Abdominal Aortic Aneurysm Drug Sales, Revenue and Market Share by Country
8.1.1 South America Abdominal Aortic Aneurysm Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Abdominal Aortic Aneurysm Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Abdominal Aortic Aneurysm Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Abdominal Aortic Aneurysm Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Abdominal Aortic Aneurysm Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Abdominal Aortic Aneurysm Drug Sales and Market Share by Type (2015-2020)
10.2 Global Abdominal Aortic Aneurysm Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Abdominal Aortic Aneurysm Drug Price by Type (2015-2020)
11 Global Abdominal Aortic Aneurysm Drug Market Segment by Application
11.1 Global Abdominal Aortic Aneurysm Drug Sales Market Share by Application (2015-2020)
11.2 Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Application (2015-2020)
11.3 Global Abdominal Aortic Aneurysm Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Abdominal Aortic Aneurysm Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Abdominal Aortic Aneurysm Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Abdominal Aortic Aneurysm Drug Market Forecast (2021-2025)
12.2.2 Europe Abdominal Aortic Aneurysm Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Abdominal Aortic Aneurysm Drug Market Forecast (2021-2025)
12.2.4 South America Abdominal Aortic Aneurysm Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Abdominal Aortic Aneurysm Drug Market Forecast (2021-2025)
12.3 Abdominal Aortic Aneurysm Drug Market Forecast by Type (2021-2025)
12.3.1 Global Abdominal Aortic Aneurysm Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Abdominal Aortic Aneurysm Drug Market Share Forecast by Type (2021-2025)
12.4 Abdominal Aortic Aneurysm Drug Market Forecast by Application (2021-2025)
12.4.1 Global Abdominal Aortic Aneurysm Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Abdominal Aortic Aneurysm Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Abdominal Aortic Aneurysm Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Abdominal Aortic Aneurysm Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Abdominal Aortic Aneurysm Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. AstraZeneca Plc Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Plc Abdominal Aortic Aneurysm Drug Major Business
Table 9. AstraZeneca Plc Abdominal Aortic Aneurysm Drug Total Revenue (USD Million) (2017-2018)
Table 10. AstraZeneca Plc SWOT Analysis
Table 11. AstraZeneca Plc Abdominal Aortic Aneurysm Drug Product and Services
Table 12. AstraZeneca Plc Abdominal Aortic Aneurysm Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Vida Therapeutics Inc. Basic Information, Manufacturing Base and Competitors
Table 14. Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Major Business
Table 15. Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Total Revenue (USD Million) (2017-2018)
Table 16. Vida Therapeutics Inc. SWOT Analysis
Table 17. Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Product and Services
Table 18. Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Carolus Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 20. Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Major Business
Table 21. Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Total Revenue (USD Million) (2017-2018)
Table 22. Carolus Therapeutics, Inc. SWOT Analysis
Table 23. Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Product and Services
Table 24. Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 26. Novartis AG Abdominal Aortic Aneurysm Drug Major Business
Table 27. Novartis AG Abdominal Aortic Aneurysm Drug Total Revenue (USD Million) (2017-2018)
Table 28. Novartis AG SWOT Analysis
Table 29. Novartis AG Abdominal Aortic Aneurysm Drug Product and Services
Table 30. Novartis AG Abdominal Aortic Aneurysm Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Global Abdominal Aortic Aneurysm Drug Sales by Manufacturer (2018-2019) (K Pcs)
Table 32. Global Abdominal Aortic Aneurysm Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 33. Global Abdominal Aortic Aneurysm Drug Sales by Regions (2015-2020) (K Pcs)
Table 34. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Regions (2015-2020)
Table 35. Global Abdominal Aortic Aneurysm Drug Revenue by Regions (2015-2020) (USD Million)
Table 36. North America Abdominal Aortic Aneurysm Drug Sales by Countries (2015-2020) (K Pcs)
Table 37. North America Abdominal Aortic Aneurysm Drug Sales Market Share by Countries (2015-2020)
Table 38. North America Abdominal Aortic Aneurysm Drug Revenue by Countries (2015-2020) (USD Million)
Table 39. North America Abdominal Aortic Aneurysm Drug Revenue Market Share by Countries (2015-2020)
Table 40. Europe Abdominal Aortic Aneurysm Drug Sales by Countries (2015-2020) (K Pcs)
Table 41. Europe Abdominal Aortic Aneurysm Drug Sales Market Share by Countries (2015-2020)
Table 42. Europe Abdominal Aortic Aneurysm Drug Revenue by Countries (2015-2020) (USD Million)
Table 43. Asia-Pacific Abdominal Aortic Aneurysm Drug Sales by Regions (2015-2020) (K Pcs)
Table 44. Asia-Pacific Abdominal Aortic Aneurysm Drug Sales Market Share by Regions (2015-2020)
Table 45. Asia-Pacific Abdominal Aortic Aneurysm Drug Revenue by Regions (2015-2020) (USD Million)
Table 46. South America Abdominal Aortic Aneurysm Drug Sales by Countries (2015-2020) (K Pcs)
Table 47. South America Abdominal Aortic Aneurysm Drug Sales Market Share by Countries (2015-2020)
Table 48. South America Abdominal Aortic Aneurysm Drug Revenue by Countries (2015-2020) (USD Million)
Table 49. South America Abdominal Aortic Aneurysm Drug Revenue Market Share by Countries (2015-2020)
Table 50. Middle East & Africa Abdominal Aortic Aneurysm Drug Sales by Countries (2015-2020) (K Pcs)
Table 51. Middle East & Africa Abdominal Aortic Aneurysm Drug Sales Market Share by Countries (2015-2020)
Table 52. Middle East & Africa Abdominal Aortic Aneurysm Drug Revenue by Countries (2015-2020) (USD Million)
Table 53. Middle East & Africa Abdominal Aortic Aneurysm Drug Revenue Market Share by Countries (2015-2020)
Table 54. Global Abdominal Aortic Aneurysm Drug Sales by Type (2015-2020) (K Pcs)
Table 55. Global Abdominal Aortic Aneurysm Drug Sales Share by Type (2015-2020)
Table 56. Global Abdominal Aortic Aneurysm Drug Revenue by Type (2015-2020) (USD Million)
Table 57. Global Abdominal Aortic Aneurysm Drug Revenue Share by Type (2015-2020)
Table 58. Global Abdominal Aortic Aneurysm Drug Sales by Application (2015-2020) (K Pcs)
Table 59. Global Abdominal Aortic Aneurysm Drug Sales Share by Application (2015-2020)
Table 60. Global Abdominal Aortic Aneurysm Drug Sales Forecast by Regions (2021-2025) (K Pcs)
Table 61. Global Abdominal Aortic Aneurysm Drug Market Share Forecast by Regions (2021-2025)
Table 62. Global Abdominal Aortic Aneurysm Drug Sales Forecast by Type (2021-2025) (K Pcs)
Table 63. Global Abdominal Aortic Aneurysm Drug Market Share Forecast by Type (2021-2025)
Table 64. Global Abdominal Aortic Aneurysm Drug Sales Forecast by Application (2021-2025)
Table 65. Global Abdominal Aortic Aneurysm Drug Market Share Forecast by Application (2021-2025)
Table 66. Direct Channel Pros & Cons
Table 67. Indirect Channel Pros & Cons
Table 68. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Abdominal Aortic Aneurysm Drug Picture
Figure 2. Global Sales Market Share of Abdominal Aortic Aneurysm Drug by Type in 2019
Figure 3. BSN-908 Picture
Figure 4. Canakinumab Picture
Figure 5. CT-2009 Picture
Figure 6. Ticagrelor Picture
Figure 7. Others Picture
Figure 8. Abdominal Aortic Aneurysm Drug Sales Market Share by Application in 2018
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Others Picture
Figure 12. Global Abdominal Aortic Aneurysm Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Abdominal Aortic Aneurysm Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Abdominal Aortic Aneurysm Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Abdominal Aortic Aneurysm Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Abdominal Aortic Aneurysm Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Abdominal Aortic Aneurysm Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Abdominal Aortic Aneurysm Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Abdominal Aortic Aneurysm Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Abdominal Aortic Aneurysm Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Abdominal Aortic Aneurysm Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Abdominal Aortic Aneurysm Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Abdominal Aortic Aneurysm Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Abdominal Aortic Aneurysm Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Abdominal Aortic Aneurysm Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Abdominal Aortic Aneurysm Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Abdominal Aortic Aneurysm Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Abdominal Aortic Aneurysm Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Abdominal Aortic Aneurysm Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Abdominal Aortic Aneurysm Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Abdominal Aortic Aneurysm Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Manufacturer in 2019
Figure 33. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Abdominal Aortic Aneurysm Drug Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Abdominal Aortic Aneurysm Drug Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 38. Global Abdominal Aortic Aneurysm Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Regions (2015-2020)
Figure 40. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Regions in 2018
Figure 41. North America Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020)
Figure 42. Europe Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020)
Figure 44. South America Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020)
Figure 46. North America Abdominal Aortic Aneurysm Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Abdominal Aortic Aneurysm Drug Sales Market Share by Countries (2015-2020)
Figure 48. North America Abdominal Aortic Aneurysm Drug Sales Market Share by Countries in 2018
Figure 49. North America Abdominal Aortic Aneurysm Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Abdominal Aortic Aneurysm Drug Revenue Market Share by Countries in 2018
Figure 51. United States Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Canada Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Mexico Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Europe Abdominal Aortic Aneurysm Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Abdominal Aortic Aneurysm Drug Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Abdominal Aortic Aneurysm Drug Revenue Market Share by Countries in 2019
Figure 57. Germany Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. UK Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. France Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Asia-Pacific Abdominal Aortic Aneurysm Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Abdominal Aortic Aneurysm Drug Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Abdominal Aortic Aneurysm Drug Revenue Market Share by Regions 2019
Figure 65. China Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Korea Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. India Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Southeast Asia Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. South America Abdominal Aortic Aneurysm Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Abdominal Aortic Aneurysm Drug Sales Market Share by Countries in 2019
Figure 72. South America Abdominal Aortic Aneurysm Drug Revenue Market Share by Countries in 2019
Figure 73. Brazil Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Argentina Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Egypt Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Turkey Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. South Africa Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Global Abdominal Aortic Aneurysm Drug Sales and Growth Rate (2021-2025) (K Pcs)
Figure 84. Global Abdominal Aortic Aneurysm Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Abdominal Aortic Aneurysm Drug Market Forecast (2021-2025) (K Pcs)
Figure 86. Europe Sales Abdominal Aortic Aneurysm Drug Market Forecast (2021-2025) (K Pcs)
Figure 87. Asia-Pacific Sales Abdominal Aortic Aneurysm Drug Market Forecast (2021-2025) (K Pcs)
Figure 88. South America Sales Abdominal Aortic Aneurysm Drug Market Forecast (2021-2025) (K Pcs)
Figure 89. Middle East & Africa Sales Abdominal Aortic Aneurysm Drug Market Forecast (2021-2025) (K Pcs)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel

以下、関連資料のご紹介
  • 腹部大動脈瘤薬の世界市場（～2026年）
    Global Abdominal Aortic Aneurysm Drug Market Insights and Forecast to 2026
    MRC2-11QY02000 2020年11月20日 113Pages
    当調査資料は腹部大動脈瘤薬のグローバル市場について調査・分析したレポートです。種類別（BSN-908、カナキヌマブ、CT-2009、チカグレロル、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日...
  • 腹部大動脈瘤治療の世界市場（～2026年）
    Global Abdominal Aortic Aneurysm Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY13540 2020年11月30日 93Pages
    当調査資料は腹部大動脈瘤治療のグローバル市場について調査・分析したレポートです。種類別（手術、薬物）市場規模、用途別（病院、診療所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ...
  • 腹部大動脈瘤（AAA）修復装置の世界市場2020年：メーカー別、地域別、種類・用途別
    Global Abdominal Aortic Aneurysm (AAA) Repair Devices Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    MRC2012A0005 2020年12月21日 109Pages
    本調査レポートでは、腹部大動脈瘤（AAA）修復装置の世界市場を広く調査・分析し、今後の市場展望をまとめております。腹部大動脈瘤（AAA）修復装置の種類別市場規模（血管内ステントグラフト、合成移植片、カテーテルデバイス）、用途別市場規模（腎臓下AAA、副腎AAA、腎傍AAA）、地域別市場規模（北米、ア...
  • 血管内動脈瘤修復術（EVAR）の世界市場（～2026年）
    Global Endovascular Aneurysm Repair (EVAR) Market Size, Status and Forecast 2020-2026
    MRC2-11QY11822 2020年11月25日 97Pages
    当調査資料は血管内動脈瘤修復術（EVAR）のグローバル市場について調査・分析したレポートです。種類別（腹部大動脈瘤（AAA）、胸部大動脈瘤（TAA）、胸腹部大動脈瘤（TAAA））市場規模、用途別（病院、外来手術センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギ...
  • 大動脈インターベンションの世界市場（～2026年）
    Global Aortic Intervention Market Size, Status and Forecast 2020-2026
    MRC2-11QY10883 2020年11月25日 91Pages
    当調査資料は大動脈インターベンションのグローバル市場について調査・分析したレポートです。種類別（腹部大動脈ステントグラフト、胸部大動脈ステントグラフト、有窓大動脈ステントグラフト、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギ...
  • 大動脈ステントグラフトの世界市場2020年：メーカー別、地域別、種類・用途別
    Global Aortic Stents Grafts Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    MRC2012A0594 2020年12月21日 105Pages
    本調査レポートでは、大動脈ステントグラフトの世界市場を広く調査・分析し、今後の市場展望をまとめております。大動脈ステントグラフトの種類別市場規模（腹部大動脈ステントグラフト、胸部大動脈ステントグラフト）、用途別市場規模（病院、外来手術センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中...
  • 大動脈内バルーンカウンターパルセーションデバイスの世界市場2020年：メーカー別、地域別、種類・用途別
    Global Intra-aortic Balloon Counterpulsation Device Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    MRC2012A5121 2020年12月21日 105Pages
    本調査レポートでは、大動脈内バルーンカウンターパルセーションデバイスの世界市場を広く調査・分析し、今後の市場展望をまとめております。大動脈内バルーンカウンターパルセーションデバイスの種類別市場規模（一般タイプ、光ファイバータイプ）、用途別市場規模（心臓移植、急性冠症候群、切迫心筋梗塞、心原性ショック...
  • 経カテーテル大動脈弁留置術（TAVI）の世界市場（～2026年）
    Global Transcatheter Aortic Valve Implantation (TAVI) Market Size, Status and Forecast 2020-2026
    MRC2-11QY04879 2020年11月20日 94Pages
    当調査資料は経カテーテル大動脈弁留置術（TAVI）のグローバル市場について調査・分析したレポートです。種類別（経大腿アプローチ、経心尖アプローチ、その他）市場規模、用途別（大動脈弁狭窄症、大動脈弁逆流、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロ...
  • 経カテーテル大動脈弁置換術の世界市場（～2026年）
    Global Transcatheter Aortic Valve Replacement Market Size, Status and Forecast 2020-2026
    MRC2-11QY04880 2020年11月20日 96Pages
    当調査資料は経カテーテル大動脈弁置換術のグローバル市場について調査・分析したレポートです。種類別（経大腿アプローチ、経心尖アプローチ、その他）市場規模、用途別（大動脈弁狭窄症、大動脈弁逆流、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア...
  • 腹腔手術用画像の世界市場2020年：メーカー別、地域別、種類・用途別
    Global Abdominal Cavity Surgical Imaging Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    MRC2012A0008 2020年12月21日 103Pages
    本調査レポートでは、腹腔手術用画像の世界市場を広く調査・分析し、今後の市場展望をまとめております。腹腔手術用画像の種類別市場規模（モバイルCアーム、ミニCアーム）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカ...
  • 腹部大動脈瘤薬の世界市場（～2026年）腹部大動脈瘤薬の世界市場（～2026年） Market Analysis and Insights: Global Abdominal Aortic Aneurysm Drug Market The global Abdominal Aortic Aneurysm Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Abdominal Aortic Aneurysm Drug Scope and Market Size …
  • 腹部大動脈瘤治療の世界市場（～2026年）腹部大動脈瘤治療の世界市場（～2026年） The walls of the aorta can swell or bulge out like a small balloon if they become weak is called an abdominal aortic aneurysm (AAA) when it happens in the part of the aorta that’s in your abdomen. There is however investment in R&D across the globe for the development of drugs for abdominal aortic a…
  • 腹部大動脈瘤（AAA）修復装置の世界市場2020年：メーカー別、地域別、種類・用途別腹部大動脈瘤（AAA）修復装置の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Abdominal Aortic Aneurysm (AAA) Repair Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, …
  • 血管内動脈瘤修復術（EVAR）の世界市場（～2026年）血管内動脈瘤修復術（EVAR）の世界市場（～2026年） Endovascular aneurysm repair (or endovascular aortic repair) (EVAR) is a type of endovascular surgery used to treat pathology of the aorta. In this medical procedure Stent graft is placed inside an Aorta without removing any tissue from patients Aorta as it's required in open aortic surgery. Endovas…
  • 大動脈インターベンションの世界市場（～2026年）大動脈インターベンションの世界市場（～2026年） Aorta is the largest artery in the human body that arises from the left ventricle of the heart and travels to the abdomen. It is divided into different branches that reach to the chest, abdomen and leg of the body. Aorta serves as the supplier of the oxygenated blood to all these organs and tissues.…